HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fuyuki Sato Selected Research

Basic Helix-Loop-Helix Transcription Factors

11/2020Dec1 deficiency protects the heart from fibrosis, inflammation, and myocardial cell apoptosis in a mouse model of cardiac hypertrophy.
1/2020Potential Role of DEC1 in Cervical Cancer Cells Involving Overexpression and Apoptosis.
10/2019Dec1 Deficiency Suppresses Cardiac Perivascular Fibrosis Induced by Transverse Aortic Constriction.
1/2016DEC1 and DEC2 Crosstalk between Circadian Rhythm and Tumor Progression.
10/2012The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer.
9/2012The basic helix-loop-helix transcription factor DEC2 inhibits TGF-β-induced tumor progression in human pancreatic cancer BxPC-3 cells.
4/2012BHLH transcription factor DEC2 regulates pro-apoptotic factor Bim in human oral cancer HSC-3 cells.
4/2011Basic helix-loop-helix transcription factors DEC1 and DEC2 regulate the paclitaxel-induced apoptotic pathway of MCF-7 human breast cancer cells.
4/2010Anti-apoptotic effect of the basic helix-loop-helix (bHLH) transcription factor DEC2 in human breast cancer cells.
2/2008Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fuyuki Sato Research Topics

Disease

25Neoplasms (Cancer)
01/2022 - 01/2005
8Hypoxia (Hypoxemia)
01/2016 - 02/2008
6Mouth Neoplasms (Oral Cancer)
08/2019 - 10/2007
5Neoplasm Metastasis (Metastasis)
01/2020 - 01/2005
4Pancreatic Neoplasms (Pancreatic Cancer)
10/2012 - 04/2008
4Breast Neoplasms (Breast Cancer)
04/2011 - 08/2007
3Inflammation (Inflammations)
06/2021 - 10/2012
3Squamous Cell Carcinoma of Head and Neck
12/2019 - 01/2005
3Carcinoma (Carcinomatosis)
04/2010 - 11/2008
2Fibrosis (Cirrhosis)
11/2020 - 10/2019
2Esophageal Squamous Cell Carcinoma
04/2010 - 04/2008
2Carcinogenesis
04/2008 - 08/2007
1Prostatic Neoplasms (Prostate Cancer)
12/2021
1Liposarcoma
12/2020
1Cardiomegaly (Heart Hypertrophy)
11/2020
1Anaplastic Thyroid Carcinoma
10/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020
1Heart Diseases (Heart Disease)
10/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2019
1Insulin Resistance
01/2018
1Myxoid Liposarcoma
01/2017
1Rheumatoid Arthritis
01/2016
1Vascular Calcification
12/2014
1Mesothelioma
09/2014
1Virus Diseases (Viral Diseases)
01/2011
1Colitis
11/2010
1Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2010
1Disease Progression
11/2010
1Lymphatic Metastasis
04/2010
1Adenocarcinoma
04/2009
1Hepatocellular Carcinoma (Hepatoma)
01/2009
1Esophageal Neoplasms (Esophageal Cancer)
04/2008

Drug/Important Bio-Agent (IBA)

10Basic Helix-Loop-Helix Transcription FactorsIBA
11/2020 - 02/2008
7Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2005
4Claudin-1IBA
10/2010 - 08/2007
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2019 - 04/2008
3CytokinesIBA
01/2017 - 10/2012
2Proliferating Cell Nuclear Antigen (PCNA)IBA
01/2022 - 08/2019
2Oncogene Proteins (Oncogene Protein)IBA
12/2020 - 01/2017
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 07/2011
2Transforming Growth Factor beta (TGF-beta)IBA
10/2019 - 01/2016
2Transforming Growth Factors (Transforming Growth Factor)IBA
12/2014 - 09/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2012 - 02/2008
2Claudin-4IBA
10/2012 - 08/2007
2Small Interfering RNA (siRNA)IBA
09/2012 - 10/2010
1Caseins (Casein)FDA Link
01/2022
1ChemokinesIBA
12/2021
1Carrier Proteins (Binding Protein)IBA
12/2021
1Epidermal Growth Factor (EGF)IBA
12/2021
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
12/2021
1Phosphotransferases (Kinase)IBA
12/2021
1LigandsIBA
12/2021
1FatsIBA
08/2021
1LipopolysaccharidesIBA
06/2021
1InflammasomesIBA
06/2021
1CCAAT-Enhancer-Binding ProteinsIBA
12/2020
1MicroRNAs (MicroRNA)IBA
10/2020
1Keratin-17 (Keratin 17)IBA
12/2019
1Large Neutral Amino Acid-Transporter 1IBA
10/2019
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
10/2019
12- amino- 3- (4- ((5- amino- 2- phenylbenzo(d)oxazol- 7- yl)methoxy)- 3,5- dichlorophenyl)propanoic acidIBA
10/2019
1CyclinsIBA
10/2019
1S100 Calcium-Binding Protein A4IBA
10/2019
1OccludinIBA
08/2019
1Insulin (Novolin)FDA Link
01/2018
1SteroidsIBA
01/2016
1LuciferasesIBA
12/2014
1Serum-Free Culture MediaIBA
09/2014
1Transcription Factors (Transcription Factor)IBA
10/2012
1Cyclin D1IBA
07/2011
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
07/2011
1Pharmaceutical PreparationsIBA
07/2011
1Paclitaxel (Taxol)FDA LinkGeneric
04/2011
1Poly I-CIBA
01/2011
1Double-Stranded RNA (RNA, Double Stranded)IBA
01/2011
1Interleukin-12 (IL 12)IBA
11/2010
1Proteoglycans (Proteoglycan)IBA
11/2010
1Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2010
1Interleukin-6 (Interleukin 6)IBA
11/2010
1Interleukin-10 (Interleukin 10)IBA
11/2010
1interleukin-21 (interleukin 21)IBA
11/2010
1Interleukin-17 (Interleukin 17)IBA
11/2010
1Interleukin-23 Subunit p19IBA
11/2010
1Membrane Proteins (Integral Membrane Proteins)IBA
10/2010
1TamoxifenFDA LinkGeneric
10/2010
1VimentinIBA
04/2010
1Calbindin 2IBA
11/2009
1Cadherins (E-Cadherin)IBA
04/2009
1Glycoproteins (Glycoprotein)IBA
04/2009
1Syndecan-1 (Syndecan 1)IBA
04/2009
1T0901317IBA
01/2009
1Hormones (Hormone)IBA
11/2008
1Irinotecan (Camptosar)FDA LinkGeneric
10/2008
1GemcitabineFDA Link
10/2008
1Docetaxel (Taxotere)FDA Link
10/2008
1Indicators and Reagents (Reagents)IBA
04/2008

Therapy/Procedure

3Therapeutics
10/2020 - 11/2008
1Oral Administration
11/2010
1Prostatectomy (Retropubic Prostatectomy)
11/2008
1Drug Therapy (Chemotherapy)
10/2008